Search
for
Sort by
Research 31–60 of 1000+
- Effect of PTPN22, FAS/FASL, IL2RA and CTLA4 genetic polymorphisms on the risk of developing alopecia areata: A systematic review of the literature and meta-analysis
- Distribution of human B-defensin 2, TNF-alpha, IL-1 alpha, IL-6 and IL-8 in psoriatic skin
- Sequential Immunotherapy with Tofacitinib and Low-Dose IL-2 Induces Sustained Remission in Alopecia Areata: A Proof-of-concept monocentric study
- Antigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 Diabetes
- CD8-positive Lymphocytes in Graft-Versus-Host Disease of Humanized NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ Mice
- Dermatologic Changes Associated With Interleukin 2 Administration
- Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease‐associated psychological morbidity
- New onset of alopecia areata in a patient with SARS‐CoV‐2 infection: Possible pathogenetic correlations?
- Recurrence of Pemphigus Vulgaris Associated With Interleukin 2 Therapy
- Innate type 2 immunity controls hair follicle commensalism by Demodex mites
- Single‐cell transcriptomics reveals a senescence‐associated IL ‐6/ CCR6 axis driving radiodermatitis
- Type 2 Cytokine–Dependent Skin Barrier Regulation in Personalized 2-Dimensional and 3-Dimensional Skin Models of Atopic Dermatitis: A Pilot Study
- 265 Modulation of disease-central cytokine pathways with TAK-279, a highly selective oral tyrosine kinase 2 (TYK2) inhibitor, defines clinical response in patients with psoriasis
- Effect of diode pumping solid state laser with wavelength 589 nm on gene expression of interlukine-2 and interferon-gamma Lowercase in human T-lymphocytes
- Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
- Detection of Serum Levels of Interleukins-17, 21, 6 and Tumor Necrosis Factor-α in Patients with Patchy Alopecia Areata and Their Association with Disease Severity
- CGF therapy: bridging androgenetic alopecia observations to psoriasis treatment via IL-17 pathway
- 219 Clinical and immunological impact of booster immunization with recombinant mRNA vaccines for SARS-CoV-2 in patients with pemphigus and bullous pemphigoid
- 1318 Both lesional and non-lesional skin from acne patients shows robust IL-17-skewing and upregulation of antimicrobial peptides
- 269 Down-regulatory role of cholecystokinin on psoriatic epidermal inflammation
- Medicom Conference Report WCD 2023
- 1396 Interferon-24 regulates the expression of MMP1 and dermal collagen of the skin
- 224 Humoral immune response to COVID-19 vaccination in psoriasis patients on biologic therapy is impaired compared to healthy controls
- 1617 Impact of type 2 cytokines on the keratinocytes-s. aureus interaction
- Scientific Highlights from the Society for Investigative Dermatology 2010 Annual Meeting
- Chemical Constituents from Osmanthus fragrans var. aurantiacus Makino with Their In Vitro and In Silico Studies Target Anti-Inflammation by Suppressing ERK 1/2 MAPK Signaling
- 1497 Type 2-mediated oxidative reprogramming promotes the transition of macrophages into repair mode and is required for wound healing
- Type 2 innate immunity regulates hair follicle homeostasis to control <i>Demodex</i> pathosymbionts
- A 20-year retrospective clinicopathologic study on melanoma in Singapore
- 24 ARQ-234: a high affinity CD200-Fc fusion protein for the treatment of atopic dermatitis